BGAI
RVMD icon

Bruce G. Allen Investments’s Revolution Medicines RVMD Stock Holding History

Bruce G. Allen Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5K Buy
+8
New +$1.17K ﹤0.01% 739

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bruce G. Allen Investments's RVMD Position: Q2 2026 in Review

Bruce G. Allen Investments opened a new position in Revolution Medicines (RVMD) in Q2 2026: 8 shares worth $1.5K. The stake represents ﹤0.01% of the portfolio and ranks #739 among its holdings.

688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bruce G. Allen Investments held 8 shares of Revolution Medicines worth $1.5K as of Q2 2026.
  • Revolution Medicines was a new Bruce G. Allen Investments position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #739 holding.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.